The Use of Parenteral Iron Formulations in Anemia in Patients with Chronic Kidney Diseas
Iron preparations- an obligatory element of the complex therapyof anemiain patients withchronic kidney diseaseaccording to international recommendations.When choosing aoral and parenteralformsin most casesin practice, preference is given topreparationsfor intravenous use, Fe saharatis.
Main Authors: | Ya.A. Dombrovskyi, D.D. Ivanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2015-10-01
|
Series: | Počki |
Online Access: | http://kidneys.zaslavsky.com.ua/article/view/74901 |
Similar Items
-
Intravenous Iron Drugs Usage in the Treatment of Iron Deficiency Anemia in Patients with Chronic Kidney Disease
by: D.D. Ivanov, et al.
Published: (2016-08-01) -
The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
by: D.D. Ivanov, et al.
Published: (2015-04-01) -
The use of ceruloplasmin drugs for correction of anemia and intoxication in patients with chronic kidney disease
by: Ya.A. Dombrovskyi, et al.
Published: (2014-02-01) -
Alpha-erythropoietin in the treatment and prevention of anemia in patients with chronic kidney disease
by: Ya.A. Dombrovskyi, et al.
Published: (2014-02-01) -
Use of Hyaluronic Acid Preparations in the Treatment of Chronic Cystitis
by: D.D. Ivanov, et al.
Published: (2015-08-01)